GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SPIC
|
ENSG00000166211.6 | Spi-C transcription factor |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_121379739 | 67.66 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr12_-_15114603 | 58.42 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr16_+_30194916 | 55.19 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr1_-_160681593 | 51.35 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
chr12_-_15114492 | 50.41 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr12_+_54892550 | 49.15 |
ENST00000545638.2
|
NCKAP1L
|
NCK-associated protein 1-like |
chr13_-_46756351 | 48.29 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr19_+_49838653 | 47.81 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr6_+_31554826 | 46.39 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr6_-_32557610 | 45.85 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
chr4_-_103682071 | 44.81 |
ENST00000505239.1
|
MANBA
|
mannosidase, beta A, lysosomal |
chr19_-_10446449 | 43.29 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr13_+_31309645 | 40.77 |
ENST00000380490.3
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein |
chr19_-_8642289 | 39.96 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
chr12_+_25205666 | 39.63 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
chr1_-_31230650 | 38.73 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr12_+_25205568 | 38.24 |
ENST00000548766.1
ENST00000556887.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr14_-_23285011 | 37.59 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr14_-_23285069 | 37.40 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr1_-_183560011 | 37.18 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
chr22_+_23247030 | 36.84 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr22_+_37309662 | 36.05 |
ENST00000403662.3
ENST00000262825.5 |
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
chr22_+_37257015 | 35.51 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chrX_-_107018969 | 35.26 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr16_-_88717482 | 35.00 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr4_-_74853897 | 34.79 |
ENST00000296028.3
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
chr17_-_29641104 | 33.98 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr1_+_111415757 | 33.90 |
ENST00000429072.2
ENST00000271324.5 |
CD53
|
CD53 molecule |
chr12_+_7055767 | 32.42 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr7_+_74188309 | 32.40 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chr21_-_46340884 | 31.48 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr6_+_31582961 | 31.45 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
chr16_+_81812863 | 31.08 |
ENST00000359376.3
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
chr21_-_46340770 | 30.16 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr16_-_88717423 | 29.92 |
ENST00000568278.1
ENST00000569359.1 ENST00000567174.1 |
CYBA
|
cytochrome b-245, alpha polypeptide |
chr19_-_10450328 | 29.79 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr1_-_150738261 | 29.50 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr12_+_54891495 | 29.43 |
ENST00000293373.6
|
NCKAP1L
|
NCK-associated protein 1-like |
chr19_-_39826639 | 29.23 |
ENST00000602185.1
ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG
|
glia maturation factor, gamma |
chr12_+_7055631 | 29.08 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_+_31554779 | 28.89 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr19_-_10450287 | 28.77 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr2_+_143886877 | 28.67 |
ENST00000295095.6
|
ARHGAP15
|
Rho GTPase activating protein 15 |
chr1_-_25256368 | 28.46 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr17_-_29641084 | 27.78 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr19_-_39108568 | 26.95 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr11_+_1874200 | 24.79 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr10_-_98031310 | 24.73 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
chrX_-_47489244 | 24.21 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
chr1_-_183559693 | 23.80 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr17_-_20370847 | 23.79 |
ENST00000423676.3
ENST00000324290.5 |
LGALS9B
|
lectin, galactoside-binding, soluble, 9B |
chr19_+_13261216 | 23.46 |
ENST00000587885.1
ENST00000292433.3 |
IER2
|
immediate early response 2 |
chr5_-_140013275 | 23.24 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr17_+_72462525 | 22.67 |
ENST00000360141.3
|
CD300A
|
CD300a molecule |
chr6_+_31553978 | 22.54 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
chr11_-_615570 | 22.49 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr19_+_42381337 | 22.18 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr11_-_615942 | 22.02 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr2_+_233925064 | 21.57 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
chr19_-_54784937 | 21.35 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr10_-_98031265 | 21.13 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
chr9_+_134000948 | 20.69 |
ENST00000359428.5
ENST00000411637.2 ENST00000451030.1 |
NUP214
|
nucleoporin 214kDa |
chr16_+_31271274 | 20.68 |
ENST00000287497.8
ENST00000544665.3 |
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit) |
chr19_-_39108552 | 20.58 |
ENST00000591517.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr6_+_31554612 | 20.36 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
chr3_+_16926441 | 20.24 |
ENST00000418129.2
ENST00000396755.2 |
PLCL2
|
phospholipase C-like 2 |
chr6_-_133079022 | 19.97 |
ENST00000525289.1
ENST00000326499.6 |
VNN2
|
vanin 2 |
chr5_-_130970723 | 19.85 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr12_-_7656357 | 19.78 |
ENST00000396620.3
ENST00000432237.2 ENST00000359156.4 |
CD163
|
CD163 molecule |
chr7_+_150264365 | 19.36 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
chr19_-_39108643 | 19.31 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr14_+_88471468 | 19.17 |
ENST00000267549.3
|
GPR65
|
G protein-coupled receptor 65 |
chr17_+_34431212 | 19.16 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr4_-_103682145 | 19.14 |
ENST00000226578.4
|
MANBA
|
mannosidase, beta A, lysosomal |
chr3_-_50375657 | 18.78 |
ENST00000395126.3
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1 |
chr18_-_47813940 | 18.54 |
ENST00000586837.1
ENST00000412036.2 ENST00000589940.1 |
CXXC1
|
CXXC finger protein 1 |
chr1_-_150552006 | 18.46 |
ENST00000307940.3
ENST00000369026.2 |
MCL1
|
myeloid cell leukemia sequence 1 (BCL2-related) |
chr12_+_25205446 | 18.33 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
chr17_+_42422662 | 18.30 |
ENST00000593167.1
ENST00000585512.1 ENST00000591740.1 ENST00000592783.1 ENST00000587387.1 ENST00000588237.1 ENST00000589265.1 |
GRN
|
granulin |
chr1_+_161475208 | 18.28 |
ENST00000367972.4
ENST00000271450.6 |
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32) |
chr11_-_72463421 | 18.24 |
ENST00000393609.3
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr7_-_76829125 | 18.18 |
ENST00000248598.5
|
FGL2
|
fibrinogen-like 2 |
chr17_+_72462766 | 17.97 |
ENST00000392625.3
ENST00000361933.3 ENST00000310828.5 |
CD300A
|
CD300a molecule |
chr2_-_231084820 | 17.84 |
ENST00000258382.5
ENST00000338556.3 |
SP110
|
SP110 nuclear body protein |
chrX_+_24072833 | 17.53 |
ENST00000253039.4
|
EIF2S3
|
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa |
chr5_+_178977546 | 17.52 |
ENST00000319449.4
ENST00000377001.2 |
RUFY1
|
RUN and FYVE domain containing 1 |
chr16_-_88851618 | 17.50 |
ENST00000301015.9
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1 |
chr1_-_153518270 | 17.46 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
chr11_-_60719213 | 17.45 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr12_+_7060432 | 17.43 |
ENST00000318974.9
ENST00000456013.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_+_31553901 | 17.35 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
chr5_-_150603679 | 17.35 |
ENST00000355417.2
|
CCDC69
|
coiled-coil domain containing 69 |
chr4_+_8201091 | 17.31 |
ENST00000382521.3
ENST00000245105.3 ENST00000457650.2 ENST00000539824.1 |
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr6_+_27114861 | 17.11 |
ENST00000377459.1
|
HIST1H2AH
|
histone cluster 1, H2ah |
chrY_+_2709527 | 17.00 |
ENST00000250784.8
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr19_+_859654 | 16.90 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
chr11_+_5710919 | 16.62 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr19_-_36233332 | 16.59 |
ENST00000592537.1
ENST00000246532.1 ENST00000344990.3 ENST00000588992.1 |
IGFLR1
|
IGF-like family receptor 1 |
chr19_+_55084438 | 16.48 |
ENST00000439534.1
|
LILRA2
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 |
chr16_-_21663919 | 16.38 |
ENST00000569602.1
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr16_+_30205225 | 16.36 |
ENST00000345535.4
ENST00000251303.6 |
SLX1A
|
SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae) |
chr19_+_41903709 | 16.36 |
ENST00000542943.1
ENST00000457836.2 |
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide |
chr2_+_68592305 | 16.25 |
ENST00000234313.7
|
PLEK
|
pleckstrin |
chr6_+_31554456 | 16.05 |
ENST00000339530.4
|
LST1
|
leukocyte specific transcript 1 |
chr16_+_29465822 | 15.99 |
ENST00000330181.5
ENST00000351581.4 |
SLX1B
|
SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) |
chr2_+_182321925 | 15.92 |
ENST00000339307.4
ENST00000397033.2 |
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr19_-_51875894 | 15.90 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr22_-_37880543 | 15.86 |
ENST00000442496.1
|
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr19_+_859425 | 15.75 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
chr10_+_97471508 | 15.71 |
ENST00000453258.2
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1 |
chr14_-_89883412 | 15.66 |
ENST00000557258.1
|
FOXN3
|
forkhead box N3 |
chr19_+_6772710 | 15.57 |
ENST00000304076.2
ENST00000602142.1 ENST00000596764.1 |
VAV1
|
vav 1 guanine nucleotide exchange factor |
chr3_+_151986709 | 15.54 |
ENST00000495875.2
ENST00000493459.1 ENST00000324210.5 ENST00000459747.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr20_-_4795747 | 15.48 |
ENST00000379376.2
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr1_-_161519579 | 15.40 |
ENST00000426740.1
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr20_+_2821340 | 15.31 |
ENST00000380445.3
ENST00000380469.3 |
VPS16
|
vacuolar protein sorting 16 homolog (S. cerevisiae) |
chr14_+_21423611 | 15.26 |
ENST00000304625.2
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
chr21_-_15918618 | 15.01 |
ENST00000400564.1
ENST00000400566.1 |
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1 |
chr19_+_1041212 | 14.83 |
ENST00000433129.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr12_-_8218997 | 14.81 |
ENST00000307637.4
|
C3AR1
|
complement component 3a receptor 1 |
chr1_+_161632937 | 14.60 |
ENST00000236937.9
ENST00000367961.4 ENST00000358671.5 |
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
chr1_-_161519682 | 14.55 |
ENST00000367969.3
ENST00000443193.1 |
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr7_+_100450328 | 14.49 |
ENST00000540482.1
ENST00000418037.1 ENST00000428758.1 ENST00000275729.3 ENST00000415287.1 ENST00000354161.3 ENST00000416675.1 |
SLC12A9
|
solute carrier family 12, member 9 |
chr19_+_55128576 | 14.47 |
ENST00000396331.1
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr2_-_231084659 | 14.36 |
ENST00000258381.6
ENST00000358662.4 ENST00000455674.1 ENST00000392048.3 |
SP110
|
SP110 nuclear body protein |
chr19_+_55141861 | 14.36 |
ENST00000396327.3
ENST00000324602.7 ENST00000434867.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr19_-_13213662 | 14.30 |
ENST00000264824.4
|
LYL1
|
lymphoblastic leukemia derived sequence 1 |
chr1_+_181057638 | 14.19 |
ENST00000367577.4
|
IER5
|
immediate early response 5 |
chr2_-_231084617 | 14.08 |
ENST00000409815.2
|
SP110
|
SP110 nuclear body protein |
chr19_+_35645618 | 13.96 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chrY_+_15016725 | 13.86 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr15_-_90358048 | 13.62 |
ENST00000300060.6
ENST00000560137.1 |
ANPEP
|
alanyl (membrane) aminopeptidase |
chr19_+_55141948 | 13.41 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr7_-_150329421 | 13.38 |
ENST00000493969.1
ENST00000328902.5 |
GIMAP6
|
GTPase, IMAP family member 6 |
chr2_+_89998789 | 13.29 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr15_-_80263506 | 13.27 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr17_-_76123101 | 13.19 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
chr11_-_64647144 | 12.95 |
ENST00000359393.2
ENST00000433803.1 ENST00000411683.1 |
EHD1
|
EH-domain containing 1 |
chr17_-_34625719 | 12.93 |
ENST00000422211.2
ENST00000542124.1 |
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1 |
chr17_-_34524157 | 12.69 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
chr2_+_89999259 | 12.63 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr6_+_31554636 | 12.50 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
chr15_+_77287426 | 12.36 |
ENST00000558012.1
ENST00000267939.5 ENST00000379595.3 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr14_+_91581011 | 12.31 |
ENST00000523894.1
ENST00000522322.1 ENST00000523771.1 |
C14orf159
|
chromosome 14 open reading frame 159 |
chr16_-_21663950 | 11.91 |
ENST00000268389.4
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr16_-_15736881 | 11.89 |
ENST00000540441.2
|
KIAA0430
|
KIAA0430 |
chr11_+_43380459 | 11.80 |
ENST00000299240.6
ENST00000039989.4 |
TTC17
|
tetratricopeptide repeat domain 17 |
chr3_-_49142504 | 11.71 |
ENST00000306125.6
ENST00000420147.2 |
QARS
|
glutaminyl-tRNA synthetase |
chr1_+_149230680 | 11.65 |
ENST00000443018.1
|
RP11-403I13.5
|
RP11-403I13.5 |
chr18_-_11908329 | 11.58 |
ENST00000344987.7
ENST00000588103.1 ENST00000588191.1 ENST00000317235.7 ENST00000309976.9 ENST00000588186.1 ENST00000589267.1 |
MPPE1
|
metallophosphoesterase 1 |
chr3_+_158519654 | 11.15 |
ENST00000415822.2
ENST00000392813.4 ENST00000264266.8 |
MFSD1
|
major facilitator superfamily domain containing 1 |
chr19_-_18391708 | 11.10 |
ENST00000600972.1
|
JUND
|
jun D proto-oncogene |
chr2_+_202125219 | 11.05 |
ENST00000323492.7
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr19_+_46010674 | 10.84 |
ENST00000245932.6
ENST00000592139.1 ENST00000590603.1 |
VASP
|
vasodilator-stimulated phosphoprotein |
chr3_+_5229356 | 10.71 |
ENST00000256497.4
|
EDEM1
|
ER degradation enhancer, mannosidase alpha-like 1 |
chr17_+_18380051 | 10.70 |
ENST00000581545.1
ENST00000582333.1 ENST00000328114.6 ENST00000412421.2 ENST00000583322.1 ENST00000584941.1 |
LGALS9C
|
lectin, galactoside-binding, soluble, 9C |
chr15_-_65282274 | 10.41 |
ENST00000204566.2
|
SPG21
|
spastic paraplegia 21 (autosomal recessive, Mast syndrome) |
chr11_+_65408273 | 10.40 |
ENST00000394227.3
|
SIPA1
|
signal-induced proliferation-associated 1 |
chr17_+_37356555 | 10.12 |
ENST00000579374.1
|
RPL19
|
ribosomal protein L19 |
chr1_+_202830876 | 10.09 |
ENST00000456105.2
|
RP11-480I12.7
|
RP11-480I12.7 |
chr7_+_108210012 | 9.97 |
ENST00000249356.3
|
DNAJB9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr12_-_6772303 | 9.96 |
ENST00000396807.4
ENST00000446105.2 ENST00000341550.4 |
ING4
|
inhibitor of growth family, member 4 |
chr17_+_37356528 | 9.93 |
ENST00000225430.4
|
RPL19
|
ribosomal protein L19 |
chr17_+_37356586 | 9.91 |
ENST00000579260.1
ENST00000582193.1 |
RPL19
|
ribosomal protein L19 |
chr14_+_23340822 | 9.90 |
ENST00000359591.4
|
LRP10
|
low density lipoprotein receptor-related protein 10 |
chr19_-_19754404 | 9.90 |
ENST00000587205.1
ENST00000445806.2 ENST00000203556.4 |
GMIP
|
GEM interacting protein |
chr1_+_158985457 | 9.84 |
ENST00000567661.1
ENST00000474473.1 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr18_+_21033239 | 9.77 |
ENST00000581585.1
ENST00000577501.1 |
RIOK3
|
RIO kinase 3 |
chr19_+_35645817 | 9.71 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr16_+_89627061 | 9.67 |
ENST00000311528.5
ENST00000563270.1 ENST00000567815.1 ENST00000452368.3 ENST00000467736.1 ENST00000393099.3 |
RPL13
|
ribosomal protein L13 |
chrX_+_11776701 | 9.67 |
ENST00000476743.1
ENST00000421368.2 ENST00000398527.2 |
MSL3
|
male-specific lethal 3 homolog (Drosophila) |
chr6_+_106534192 | 9.66 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr19_+_51728316 | 9.57 |
ENST00000436584.2
ENST00000421133.2 ENST00000391796.3 ENST00000262262.4 |
CD33
|
CD33 molecule |
chr2_-_152146385 | 9.52 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr19_+_852291 | 9.47 |
ENST00000263621.1
|
ELANE
|
elastase, neutrophil expressed |
chr6_+_14117872 | 9.25 |
ENST00000379153.3
|
CD83
|
CD83 molecule |
chr16_-_15736953 | 9.25 |
ENST00000548025.1
ENST00000551742.1 ENST00000602337.1 ENST00000344181.3 ENST00000396368.3 |
KIAA0430
|
KIAA0430 |
chr16_-_87799505 | 9.25 |
ENST00000353170.5
ENST00000561825.1 ENST00000270583.5 ENST00000562261.1 ENST00000347925.5 |
KLHDC4
|
kelch domain containing 4 |
chr19_-_6481776 | 9.25 |
ENST00000543576.1
ENST00000590173.1 ENST00000381480.2 |
DENND1C
|
DENN/MADD domain containing 1C |
chr6_-_99873145 | 9.24 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
chr17_-_34417479 | 9.23 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
chr19_+_17970693 | 9.21 |
ENST00000600147.1
ENST00000599898.1 |
RPL18A
|
ribosomal protein L18a |
chr1_+_6640108 | 9.20 |
ENST00000377674.4
ENST00000488936.1 |
ZBTB48
|
zinc finger and BTB domain containing 48 |
chr10_-_27149904 | 9.18 |
ENST00000376166.1
ENST00000376138.3 ENST00000355394.4 ENST00000346832.5 ENST00000376134.3 ENST00000376137.4 ENST00000536334.1 ENST00000490841.2 |
ABI1
|
abl-interactor 1 |
chr16_+_69796209 | 9.08 |
ENST00000359154.2
ENST00000561780.1 ENST00000563659.1 ENST00000448661.1 |
WWP2
|
WW domain containing E3 ubiquitin protein ligase 2 |
chr18_-_61089665 | 9.08 |
ENST00000238497.5
|
VPS4B
|
vacuolar protein sorting 4 homolog B (S. cerevisiae) |
chr1_-_153919128 | 8.94 |
ENST00000361217.4
|
DENND4B
|
DENN/MADD domain containing 4B |
chr11_-_62380199 | 8.71 |
ENST00000419857.1
ENST00000394773.2 |
EML3
|
echinoderm microtubule associated protein like 3 |
chr18_-_53253323 | 8.65 |
ENST00000540999.1
ENST00000563888.2 |
TCF4
|
transcription factor 4 |
chr1_-_47069955 | 8.63 |
ENST00000341183.5
ENST00000496619.1 |
MKNK1
|
MAP kinase interacting serine/threonine kinase 1 |
chr3_-_49142178 | 8.63 |
ENST00000452739.1
ENST00000414533.1 ENST00000417025.1 |
QARS
|
glutaminyl-tRNA synthetase |
chr10_-_121302195 | 8.60 |
ENST00000369103.2
|
RGS10
|
regulator of G-protein signaling 10 |
chr17_-_79269067 | 8.57 |
ENST00000288439.5
ENST00000374759.3 |
SLC38A10
|
solute carrier family 38, member 10 |
chr7_-_99097863 | 8.53 |
ENST00000426306.2
ENST00000337673.6 |
ZNF394
|
zinc finger protein 394 |
chr9_+_134065506 | 8.45 |
ENST00000483497.2
|
NUP214
|
nucleoporin 214kDa |
chr9_+_125132803 | 8.42 |
ENST00000540753.1
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr11_+_2421718 | 8.37 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr3_+_47324424 | 8.36 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
chr14_-_74417096 | 8.22 |
ENST00000286544.3
|
FAM161B
|
family with sequence similarity 161, member B |
chr2_+_202122703 | 8.15 |
ENST00000447616.1
ENST00000358485.4 |
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.2 | 108.8 | GO:0071461 | cellular response to redox state(GO:0071461) |
19.6 | 78.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) actin polymerization-dependent cell motility(GO:0070358) |
18.6 | 74.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
17.2 | 51.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
17.0 | 85.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
13.8 | 55.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
13.0 | 64.9 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
12.5 | 75.0 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
12.2 | 36.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
10.6 | 42.2 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
9.2 | 45.8 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
7.9 | 23.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
7.2 | 21.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
6.8 | 20.3 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
6.7 | 20.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
6.5 | 6.5 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
6.4 | 19.2 | GO:0052053 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
6.3 | 31.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
5.8 | 23.2 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
5.3 | 21.3 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
5.2 | 67.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
5.0 | 35.3 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
4.9 | 14.8 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
4.8 | 33.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
4.6 | 18.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
4.5 | 95.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.5 | 40.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
4.4 | 17.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
4.2 | 12.7 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
4.1 | 28.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
4.0 | 63.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
4.0 | 15.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
3.8 | 122.0 | GO:0045730 | respiratory burst(GO:0045730) |
3.6 | 25.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
3.2 | 22.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
3.2 | 12.7 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
3.2 | 9.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
3.1 | 18.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
3.0 | 9.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) negative regulation of exosomal secretion(GO:1903542) regulation of centriole elongation(GO:1903722) |
3.0 | 17.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
2.9 | 66.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.8 | 48.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.8 | 69.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
2.7 | 16.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
2.7 | 10.8 | GO:1904379 | maintenance of unfolded protein(GO:0036506) protein localization to cytosolic proteasome complex(GO:1904327) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
2.6 | 25.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
2.5 | 10.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.5 | 17.3 | GO:0097319 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
2.4 | 16.8 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
2.4 | 4.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.4 | 14.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.1 | 4.2 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
2.1 | 10.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
2.1 | 12.4 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
2.0 | 46.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
2.0 | 5.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
1.9 | 17.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.9 | 5.7 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
1.9 | 11.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.8 | 5.5 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
1.8 | 5.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.7 | 153.4 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.7 | 10.2 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
1.7 | 5.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.6 | 8.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.6 | 6.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 17.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.5 | 9.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.5 | 6.1 | GO:0019086 | late viral transcription(GO:0019086) |
1.5 | 3.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
1.5 | 44.9 | GO:0010447 | response to acidic pH(GO:0010447) |
1.5 | 2.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.4 | 5.7 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.4 | 14.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.4 | 7.1 | GO:0019805 | tryptophan catabolic process to kynurenine(GO:0019441) quinolinate biosynthetic process(GO:0019805) |
1.4 | 5.6 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
1.3 | 18.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.3 | 15.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.3 | 22.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.3 | 1.3 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
1.2 | 14.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.2 | 8.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.2 | 6.0 | GO:1903026 | transcription factor catabolic process(GO:0036369) negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.2 | 10.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.2 | 7.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) regulation of receptor catabolic process(GO:2000644) |
1.2 | 19.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.2 | 15.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.1 | 5.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.1 | 3.3 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
1.1 | 6.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
1.1 | 5.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.0 | 6.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.0 | 3.1 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.0 | 3.0 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
1.0 | 27.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.0 | 7.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.0 | 8.0 | GO:0051601 | exocyst localization(GO:0051601) |
1.0 | 15.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
1.0 | 1.0 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
1.0 | 4.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.9 | 1.9 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.9 | 2.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.9 | 6.3 | GO:0007000 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) nucleolus organization(GO:0007000) |
0.9 | 7.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.9 | 5.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.9 | 4.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 2.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.8 | 2.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.8 | 7.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.8 | 3.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.8 | 7.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.7 | 22.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.7 | 4.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.7 | 2.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.7 | 4.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 3.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 17.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.7 | 6.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.7 | 3.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.7 | 7.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.7 | 12.4 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.6 | 5.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.6 | 6.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.6 | 24.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.6 | 4.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.6 | 6.0 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.6 | 97.0 | GO:0006906 | vesicle fusion(GO:0006906) |
0.6 | 8.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.6 | 3.5 | GO:0060701 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.6 | 2.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.6 | 59.9 | GO:0030183 | B cell differentiation(GO:0030183) |
0.6 | 4.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.6 | 91.9 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.6 | 5.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 3.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.5 | 2.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 1.6 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.5 | 2.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.5 | 6.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.5 | 2.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.5 | 5.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 16.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 9.7 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.5 | 1.5 | GO:0001300 | chronological cell aging(GO:0001300) |
0.5 | 18.0 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.5 | 23.1 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.5 | 8.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.5 | 8.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 6.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.5 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 3.7 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.5 | 7.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.5 | 3.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.5 | 2.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 1.8 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 4.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.4 | 7.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.4 | 9.2 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.4 | 9.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 3.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 1.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 21.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 36.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.4 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.4 | 37.0 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
0.4 | 5.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 9.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 9.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.4 | 3.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.4 | 3.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 65.4 | GO:0006909 | phagocytosis(GO:0006909) |
0.4 | 1.1 | GO:0038163 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 8.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 1.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 8.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 6.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 3.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.3 | 1.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.3 | 1.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 47.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 6.4 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.3 | 13.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 12.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.3 | 5.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.3 | 0.9 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.3 | 2.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.3 | 7.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 2.5 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 4.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 5.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 1.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.3 | 0.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.3 | 1.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 3.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 2.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 5.0 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.2 | 5.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.2 | 10.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 1.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 2.0 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 13.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 26.6 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.2 | 1.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 12.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 3.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 3.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.2 | 1.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.8 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 1.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 1.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 5.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 0.8 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.2 | 14.3 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.2 | 12.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 7.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.6 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.2 | 6.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.2 | 1.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.2 | 5.7 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.8 | GO:0071233 | cellular response to leucine(GO:0071233) cellular response to leucine starvation(GO:1990253) |
0.2 | 1.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 2.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 3.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 1.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 3.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 4.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 2.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 1.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 2.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 8.0 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 1.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 3.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 2.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 3.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) activation of JNKK activity(GO:0007256) |
0.1 | 6.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 12.8 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.1 | 5.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 12.9 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 2.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 11.8 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 7.7 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.1 | 4.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 2.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 13.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.1 | 1.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 15.3 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.8 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 35.5 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 4.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 1.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 10.9 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 1.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 8.0 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 19.9 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 7.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 4.0 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 1.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.1 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.1 | 7.5 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 7.3 | GO:0048839 | inner ear development(GO:0048839) |
0.1 | 0.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 1.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 4.1 | GO:0030100 | regulation of endocytosis(GO:0030100) |
0.1 | 1.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 10.0 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 1.3 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.0 | 1.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 1.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 2.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 1.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 1.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 2.3 | GO:0050900 | leukocyte migration(GO:0050900) |
0.0 | 0.3 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.5 | 132.0 | GO:0032010 | phagolysosome(GO:0032010) |
16.5 | 82.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
9.7 | 29.1 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
7.5 | 149.8 | GO:0001891 | phagocytic cup(GO:0001891) |
7.2 | 101.4 | GO:0031209 | SCAR complex(GO:0031209) |
7.2 | 78.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
5.0 | 64.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
4.5 | 31.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
4.3 | 13.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
4.0 | 20.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
4.0 | 15.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
3.4 | 17.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
3.3 | 16.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.2 | 22.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
3.2 | 9.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
2.7 | 10.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.6 | 10.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
2.5 | 40.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.3 | 174.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
2.2 | 17.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.2 | 45.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.9 | 5.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.8 | 5.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.8 | 24.5 | GO:0030897 | HOPS complex(GO:0030897) |
1.7 | 6.8 | GO:0055087 | Ski complex(GO:0055087) |
1.6 | 90.5 | GO:0001772 | immunological synapse(GO:0001772) |
1.4 | 5.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.4 | 18.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.4 | 25.2 | GO:0097342 | ripoptosome(GO:0097342) |
1.4 | 18.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.4 | 11.1 | GO:0035976 | AP1 complex(GO:0035976) |
1.4 | 9.7 | GO:0072487 | MSL complex(GO:0072487) |
1.4 | 17.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.3 | 5.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.3 | 5.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.1 | 23.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.0 | 3.1 | GO:0031251 | PAN complex(GO:0031251) |
1.0 | 3.1 | GO:0055028 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
1.0 | 7.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.0 | 3.0 | GO:0019034 | viral replication complex(GO:0019034) |
1.0 | 1.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.9 | 28.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 7.9 | GO:0044754 | autolysosome(GO:0044754) |
0.9 | 77.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.9 | 4.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.9 | 4.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.8 | 1.7 | GO:0032021 | NELF complex(GO:0032021) |
0.8 | 69.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.7 | 8.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.7 | 8.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 12.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 5.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 5.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 8.5 | GO:0090543 | Flemming body(GO:0090543) |
0.6 | 4.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 6.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 7.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 55.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 12.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.5 | 1.5 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.5 | 2.4 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 72.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 4.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 46.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.5 | 3.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 24.9 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 1.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.4 | 2.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 118.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 29.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 56.5 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.4 | 8.4 | GO:0042627 | chylomicron(GO:0042627) |
0.4 | 12.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.4 | 8.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 20.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 4.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.3 | 9.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 9.2 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.3 | 3.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 5.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 6.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 11.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 7.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 4.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 7.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 5.0 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 1.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 33.0 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.2 | 2.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 1.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 6.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 6.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 295.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.2 | 10.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 8.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 20.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 12.6 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 13.2 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 1.5 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 3.1 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 10.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 20.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 56.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 7.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 23.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 1.4 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 7.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 8.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 12.0 | GO:0005814 | centriole(GO:0005814) |
0.1 | 2.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 11.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 8.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 3.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 13.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 9.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 2.4 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 10.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 6.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 3.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 2.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 12.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 2.2 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 10.6 | GO:0044454 | nuclear chromosome part(GO:0044454) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 2.8 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 5.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 1.4 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 4.9 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 4.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 7.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 12.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 2.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:0005903 | brush border(GO:0005903) |
0.0 | 2.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 5.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 3.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.5 | 40.6 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
12.9 | 128.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
12.2 | 36.7 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
10.9 | 108.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
10.6 | 42.2 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
8.8 | 61.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
7.7 | 23.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
7.2 | 21.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
7.0 | 28.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
6.8 | 75.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
6.8 | 20.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
6.2 | 18.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
5.8 | 17.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
5.5 | 16.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
5.3 | 21.3 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
5.2 | 15.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
5.2 | 15.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
5.1 | 20.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
4.9 | 14.8 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
4.0 | 76.8 | GO:0015923 | mannosidase activity(GO:0015923) |
4.0 | 20.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
4.0 | 15.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.9 | 35.3 | GO:0043426 | MRF binding(GO:0043426) |
3.8 | 19.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
3.8 | 64.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
3.7 | 66.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
3.4 | 55.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.4 | 20.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
3.4 | 48.2 | GO:0019864 | IgG binding(GO:0019864) |
3.1 | 25.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.1 | 40.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.9 | 17.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.9 | 77.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.8 | 28.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.7 | 30.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.7 | 51.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.5 | 15.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
2.5 | 17.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
2.5 | 12.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
2.4 | 4.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.4 | 14.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
2.2 | 17.9 | GO:0005497 | androgen binding(GO:0005497) |
2.1 | 6.3 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
2.1 | 8.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
2.0 | 32.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.0 | 15.9 | GO:1990405 | protein antigen binding(GO:1990405) |
1.8 | 5.5 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
1.8 | 5.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.8 | 51.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.7 | 18.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.7 | 21.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.6 | 6.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.5 | 6.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.5 | 17.8 | GO:0089720 | caspase binding(GO:0089720) |
1.5 | 13.3 | GO:0051400 | BH domain binding(GO:0051400) |
1.4 | 11.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.4 | 5.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.4 | 5.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.4 | 5.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.4 | 6.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.3 | 14.8 | GO:0004875 | complement receptor activity(GO:0004875) |
1.3 | 39.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
1.3 | 7.9 | GO:0050681 | steroid hormone receptor binding(GO:0035258) androgen receptor binding(GO:0050681) |
1.3 | 6.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
1.3 | 5.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.3 | 10.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.3 | 1.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.2 | 21.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 3.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
1.1 | 15.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.1 | 18.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.1 | 7.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.1 | 5.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
1.1 | 7.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.0 | 11.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.0 | 3.0 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.9 | 19.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.9 | 21.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.9 | 1.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.9 | 17.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.9 | 91.5 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.9 | 15.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.9 | 16.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.8 | 29.5 | GO:0043236 | laminin binding(GO:0043236) |
0.8 | 7.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.8 | 7.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.8 | 6.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.8 | 12.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 2.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.7 | 5.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.7 | 9.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.7 | 16.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 2.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.7 | 9.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 5.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 10.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 4.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 3.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.6 | 7.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.6 | 2.3 | GO:0019863 | IgE binding(GO:0019863) |
0.6 | 2.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.6 | 7.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 2.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.5 | 3.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 1.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.5 | 1.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.5 | 1.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 38.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.5 | 3.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 3.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 12.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 4.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 10.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 2.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 37.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 16.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.5 | 2.8 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.5 | 78.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.5 | 28.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 16.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 5.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 6.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 5.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 2.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 18.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 4.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.4 | 9.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 2.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 16.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 10.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 3.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 5.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 4.8 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 6.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 3.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 12.5 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 4.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 15.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 5.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 6.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 0.5 | GO:0004040 | amidase activity(GO:0004040) |
0.2 | 7.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 7.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 4.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 2.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 9.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 42.4 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 2.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.5 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.0 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.2 | 27.2 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 3.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 4.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 4.2 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 1.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 2.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 3.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 3.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 2.2 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 3.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 3.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 43.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 2.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 3.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 3.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 1.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.8 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 3.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 6.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 2.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 3.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 3.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 1.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 1.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 23.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) azole transmembrane transporter activity(GO:1901474) |
0.1 | 20.0 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 5.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 10.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 4.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 1.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 14.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 12.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 4.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 3.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 3.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 5.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 6.8 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 1.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 3.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 1.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 3.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 9.2 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 3.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 17.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0001016 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 1.4 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 4.8 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 6.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 2.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 16.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 6.8 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 1.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.4 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.0 | 0.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 199.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.7 | 32.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.5 | 199.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
2.4 | 288.2 | PID BCR 5PATHWAY | BCR signaling pathway |
2.0 | 142.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.4 | 54.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.2 | 69.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.1 | 34.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.0 | 25.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.0 | 27.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.0 | 29.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 7.8 | PID EPO PATHWAY | EPO signaling pathway |
0.7 | 15.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 19.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 71.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 26.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 8.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 18.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 11.6 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 27.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 13.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 3.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 5.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 6.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 24.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 4.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 10.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 7.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 6.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 7.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 5.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 7.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 3.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 4.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 9.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 21.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 3.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 39.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 4.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 4.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.2 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 29.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.9 | 51.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
3.9 | 121.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
3.4 | 147.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
3.2 | 279.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.7 | 51.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
2.4 | 120.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.1 | 25.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.7 | 70.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.3 | 81.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.2 | 14.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.1 | 36.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.9 | 162.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.9 | 7.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.9 | 3.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.8 | 23.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.8 | 17.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 17.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.8 | 29.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 17.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.7 | 14.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.7 | 17.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.7 | 12.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 7.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 12.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 7.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 46.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 16.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.6 | 14.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 45.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.5 | 85.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 23.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 7.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 5.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.4 | 5.9 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 6.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 7.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 10.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 4.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 8.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 6.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 3.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.3 | 3.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 11.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 4.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 2.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 3.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 3.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 14.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 6.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 3.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 5.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 3.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 4.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 7.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 11.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 2.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 6.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 5.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 2.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 3.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |